Language
English
Publication Date
8-29-2023
Journal
Cell Reports
DOI
10.1016/j.celrep.2023.112946
PMID
37556325
PMCID
PMC10529316
PubMedCentral® Posted Date
9-27-2023
PubMedCentral® Full Text Version
Author MSS
Abstract
Venezuelan equine encephalitis virus (VEEV) is an encephalitic alphavirus responsible for epidemics of neurological disease across the Americas. Low-density lipoprotein receptor class A domain-containing 3 (LDLRAD3) is a recently reported entry receptor for VEEV. Here, using wild-type and Ldlrad3-deficient mice, we define a critical role for LDLRAD3 in controlling steps in VEEV infection, pathogenesis, and neurotropism. Our analysis shows that LDLRAD3 is required for efficient VEEV infection and pathogenesis prior to and after central nervous system invasion. Ldlrad3-deficient mice survive intranasal and intracranial VEEV inoculation and show reduced infection of neurons in different brain regions. As LDLRAD3 is a determinant of pathogenesis and an entry receptor required for VEEV infection of neurons of the brain, receptor-targeted therapies may hold promise as countermeasures.
Keywords
Animals, Mice, Brain, Central Nervous System, Encephalitis Virus, Venezuelan Equine, Encephalomyelitis, Venezuelan Equine, Receptors, LDL
Published Open-Access
yes
Recommended Citation
Kafai, Natasha M; Janova, Hana; Cain, Matthew D; et al., "Entry Receptor LDLRAD3 Is Required for Venezuelan Equine Encephalitis Virus Peripheral Infection and Neurotropism Leading to Pathogenesis in Mice" (2023). The Brown Foundation: Institute of Molecular Medicine. 104.
https://digitalcommons.library.tmc.edu/molecular_med/104
Graphical Abstract